UBS Group’s ETRACS Monthly Pay 1.5x Leveraged Closed-End Fund Index ETN CEFD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-94,500
Closed -$1.84M – 11230
2026
Q2
$1.84M Buy
94,500
+8,926
+10% +$168K ﹤0.01% 5181
2026
Q1
$1.5M Buy
85,574
+6,293
+8% +$119K ﹤0.01% 5221
2025
Q4
$1.52M Buy
+79,281
New +$1.53M ﹤0.01% 5202
2025
Q1
– Sell
-79
Closed -$1.55K – 10267
2024
Q4
$1.55K Buy
+79
New +$1.6K ﹤0.01% 9209
2023
Q4
– Sell
-812
Closed -$14.4K – 9354
2023
Q3
$14.4K Buy
+812
New +$15.4K ﹤0.01% 6956
2022
Q3
– Sell
-546
Closed -$12K – 10384
2022
Q2
$12K Buy
+546
New +$13.2K ﹤0.01% 7639

UBS Group's CEFD Position: Q3 2026 in Review

UBS Group sold out of ETRACS Monthly Pay 1.5x Leveraged Closed-End Fund Index ETN (CEFD) in Q3 2026, closing a stake of 94,500 shares — an estimated $1.84M sold.

UBS Group first reported a position in CEFD in Q2 2022 and held it in 6 quarters. The position peaked at $1.84M in Q2 2026. 0 funds tracked by Wall St. Rank hold CEFD as of Q3 2026.

  • UBS Group reported no remaining ETRACS Monthly Pay 1.5x Leveraged Closed-End Fund Index ETN position as of Q3 2026 after selling out during the quarter.
  • UBS Group sold 94,500 ETRACS Monthly Pay 1.5x Leveraged Closed-End Fund Index ETN shares in Q3 2026, an estimated $1.84M.
  • UBS Group first reported a position in ETRACS Monthly Pay 1.5x Leveraged Closed-End Fund Index ETN in Q2 2022 and held it in 6 quarters.
  • UBS Group's ETRACS Monthly Pay 1.5x Leveraged Closed-End Fund Index ETN position peaked at $1.84M in Q2 2026.
  • 0 funds tracked by Wall St. Rank held ETRACS Monthly Pay 1.5x Leveraged Closed-End Fund Index ETN as of Q3 2026.

Based on UBS Group's 13F filing for Q3 2026, filed 10 Nov 2026.